What is Myelodysplastic Syndrome?
Myelodysplastic syndrome is a group of diseases in which the bone marrow doesn’t produce enough healthy blood cells. Instead, it makes too many immature cells, called blasts.
These blasts die in the marrow or soon after entering the bloodstream, resulting in too few healthy blood cells and low blood counts.
In its mildest form, MDS may be anemia, low platelets or low white blood count, but about 10% to 20% of diagnosed cases progress to acute myeloid leukemia (AML).
Understanding Myelodysplastic syndrome :
To better understand what happens to your blood when you have myelodysplastic syndrome, it helps to know what makes up normal blood and bone marrow.
There are three major types of blood cells: red blood cells (RBCs), white blood cells (WBCs) and platelets. These cells are made in the bone marrow and flow through the bloodstream in a liquid called plasma.
Red blood cells (RBCs), the major part of your blood, carry oxygen and carbon dioxide throughout your body. The percentage of RBCs in the blood is called hematocrit. The part of the RBC that carries oxygen is a protein called hemoglobin.
All body tissues need oxygen to work properly. When the bone marrow is working normally, the RBC count remains stable. Anemia occurs when there are too few RBCs in the body. Symptoms of anemia include shortness of breath, weakness and fatigue.
White blood cells (WBCs) include several different types. Each has its own role in protecting the body from germs. The three major types are neutrophils, monocytes and lymphocytes.
Lymphocytes are responsible for destroying viruses and for overall management of the immune system. When lymphocytes see foreign material, they increase the body’s resistance to infection.
WBCs play a major role in fighting infection. Infections are more likely to occur when there are too few normal WBCs in the body.
Absolute neutrophil count (ANC) is a measure of the number of WBCs you have to fight infections.
Figuring out the number of ANC
You can figure out your ANC by multiplying the total number of WBCs by the percentage of neutrophils (“neuts”). The K in the report means thousands. For example:
WBC = 1000 = 1.0K
Neuts = 50% (0.5)
1000 X 0.5 = 500 neutrophils
Also, when you receive your blood counts, this equation may be written as polys plus bands = neutrophils.
Further, while anyone can catch a cold or other infections, this is more likely to occur when your ANC falls below 500.
What happen when these cells are affected ?
Your WBC count generally will fall within the first week you start chemotherapy, but it should be back to normal between 21 to 28 days after starting chemotherapy.
Platelets are the cells that help control bleeding. When you cut yourself, the platelets collect at the site of the injury and form a plug to stop the bleeding.
Bone marrow is the soft tissue within the bones where blood cells are made. The bone marrow is made up of blood cells at different stages of maturity. All blood cells begin in the bone marrow as stem cells. Stem cells are very immature cells.
When there is a need, the stem cells are signaled to develop into mature RBCs, WBCs or platelets. This signaling is done with “growth factors.”
As each cell fully matures, it is released from the bone marrow to circulate in the bloodstream. The blood circulating outside of the bone marrow in the heart, veins and arteries is called peripheral blood.
Types of Myelodysplastic Syndrome:
There are several types of MDS, and they are classified based on the number of abnormal cells in the blood and bone marrow. Types of myelodysplastic syndrome include:
Refractory anemia
Refractory cytopenia with multilineage dysplasia
Refractory anemia with ringed sideroblasts
Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
Refractory anemia with excess blasts
Myelodysplastic syndrome risk factors:
Anything that increases your chance of getting a disease is a risk factor. Most cases of myelodysplastic syndrome have no known cause, but some factors have been found to increase the risk.
Risk factors for myelodysplastic syndrome include:
Age: MDS rarely occurs in people younger than 60
Smoking tobacco
Long-term exposure to chemicals, including benzene or other chemicals used in the petroleum and rubber industries
Exposure to high levels of radiation, such a nuclear reactor accident or atomic bomb
Prior chemotherapy or radiation therapy
Inherited disorders, including:
Fanconi anemia
Shwachman-Diamond syndromes
Familial platelet disorder
Severe congenital neutropenia
Not everyone with risk factors gets MDS. However, if you have risk factors, it’s a good idea to discuss them with your health care provider.
Why having proper care is important :
A team of some of the world’s most renowned experts works together to give you personalized care, communicating closely with you and each other at every step. Your care team draws from a full range of the latest, most advanced treatments for myelodysplastic syndrome. Since long-term follow up care often is needed, we maintain a close relationship with your referring physician.
Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPN), previously called myeloproliferative disorders, are diseases of the bone marrow and blood. They can strike at any age, have no known cause and a wide range of symptoms and outlooks.
Sometimes the disease progresses slowly and requires little treatment; other times it develops into acute myeloid leukemia (AML).
Primary myelofibrosis affects the red blood cells and granulocytes, a type of white blood cell. The cells don’t mature normally and are irregularly shaped. Primary myelofibrosis also causes thickening or scarring of the fibers inside bone marrow, which can decrease the production of red blood cells and cause anemia.
Polycythemia vera (PV) is caused by the overproduction of red blood cells in the bone marrow, which then build up in the blood. Often, the spleen swells as extra blood cells collect there, causing pain or a full feeling on the left side. Itching all over the body is a symptom of PV.
Essential Thrombocythemia (ET) means that the number of platelets in the blood is much higher than normal, while other blood cell types are normal. The extra platelets make the blood “sticky,” which slows down blood flow.
Chronic eosinophilic leukemia/hypereosinophilic syndrome (HES) is characterized by a higher than normal number of the white blood cells responsible for fighting allergic reactions and some parasitic infections (eosonophils).
You may experience itching, swelling around the eyes and lips or swollen hands and/or feet. In some patients, HES may quickly progress to acute myelogenous leukemia.
Systemic mastocytosis (SM) affects mast cells, which are found in skin, connective tissue and in the lining of the stomach and intestines. Mast cells serve as a sort of alarm system by signaling disease-fighting blood cells to target areas of the body where they’re needed. They may also play a role in wound healing. SM is caused by too many mast cells accumulating in the body’s tissues, which can eventually affect the spleen, bone marrow, liver or small intestine.
Risk Factors include:
Anything that increases your chance of getting myeloproliferative neoplasms is a risk factor. These include exposure to:
- Intense radiation, such as a nuclear bomb
- Petrochemicals, such as benzene or toluene
- Electrical wiring
Many people with myeloproliferative neoplasms have a mutation in the JAK2 gene. This gene mutation is acquired, which means you are not born with it. Some cases of myeloproliferative neoplasm can be passed down from one generation to the next. Genetic counseling may be right for you.
While most oncologists see only a few patients with a myeloproliferative neoplasm in their careers, we see hundreds every month. This translates into a remarkable depth of experience and expertise, which we draw upon to give you personalized treatment.
What ACH provides you;
Myeloproliferative neoplasms, or myeloproliferative disorders, can be challenging to diagnose and treat, often requiring years of follow-up care and treatment. At ACH, , a team of experts, which may include hematologists, pathologists, advanced practice nurses and physician’s assistants, as well as a specially trained support staff, plans your treatment for myeloproliferative disease by drawing upon the very latest advancements and therapies. It all begins with precise diagnosis by our specialized pathologists, who use advanced technology and skill to pinpoint the exact disorder.